Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.

Kirn V, Shi R, Heublein S, Knabl J, Guenthner-Biller M, Andergassen U, Fridrich C, Malter W, Harder J, Friese K, Mayr D, Jeschke U.

J Cancer Res Clin Oncol. 2014 Oct;140(10):1681-7. doi: 10.1007/s00432-014-1729-9. Epub 2014 Jun 8.

PMID:
24908329
2.

Self-priming determines high type I IFN production by plasmacytoid dendritic cells.

Kim S, Kaiser V, Beier E, Bechheim M, Guenthner-Biller M, Ablasser A, Berger M, Endres S, Hartmann G, Hornung V.

Eur J Immunol. 2014 Mar;44(3):807-818. doi: 10.1002/eji.201343806. Epub 2014 Jan 16.

3.

Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients.

Engelstaedter V, Heublein S, Schumacher AL, Lenhard M, Engelstaedter H, Andergassen U, Guenthner-Biller M, Kuhn C, Rack B, Kupka M, Mayr D, Jeschke U.

BMC Cancer. 2012 Dec 15;12:600. doi: 10.1186/1471-2407-12-600.

4.

Pro-B-type natriuretic peptide as a marker of pulmonary embolism in pregnancy: a case report.

Franz MB, Guenthner-Biller MM, Kainer F, Schiessl B.

Arch Gynecol Obstet. 2008 May;277(5):439-40. doi: 10.1007/s00404-007-0468-4. Epub 2008 Feb 22.

PMID:
18293006
5.

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.

Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, Noronha A, Manoharan M, Akira S, de Fougerolles A, Endres S, Hartmann G.

Nat Med. 2005 Mar;11(3):263-70. Epub 2005 Feb 20.

PMID:
15723075
6.

Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus.

Hornung V, Schlender J, Guenthner-Biller M, Rothenfusser S, Endres S, Conzelmann KK, Hartmann G.

J Immunol. 2004 Nov 15;173(10):5935-43.

Supplemental Content

Loading ...
Support Center